Skip to main content
. 2022 Mar 6;79(3):179. doi: 10.1007/s00018-022-04153-0

Fig. 14.

Fig. 14

A Structural features carried by bFOF1 from mycobacteria. In this case the active centers of the c8-ring are found to have a special binding pocket [24, 25]. B FOF1-structure-based drug design demonstrates the molecular mechanism of inhibiting the bFOF1 by anti-tuberculosis drug BDQ.

The figure was modified from [25]